Heidari Aliehsan, Keshavarz Hossein, Rokni Mohammad B, Jelinek Tomas
Department of Medical Science, Ministry of Science (G.P.E.F), Tehran, Iran.
Korean J Parasitol. 2007 Mar;45(1):59-63. doi: 10.3347/kjp.2007.45.1.59.
Merozoite surface protein-1 (MSP-1) and merozoite surface protein-2 (MSP-2) were used to develop vaccines and to investigate the genetic diversity in Plasmodium falciparum malaria in Iran. Nested polymerase chain reaction amplification was used to determine polymorphisms of block 2 of the MSP-1 and the central domain of MSP-2 genes. A total of 67 microscopically positive P. falciparum infected individuals from a major endemic region, southeast Iran, were included in this trial. Nine alleles of MSP-1 and 11 alleles of MSP-2 were identified. The results showed that amplified product from these surface antigen genes varied in size and there was specific pattern for each isolate. Besides, regarding this pattern, 23 multiple infections with at least 2 alleles were observed. While the endemic regions of malaria in Iran is classified in low to moderate group, but extensive polymorphism was observed for each marker and the MSP-2 central repeat was the most diverse that could be considered in designing malaria vaccine.
裂殖子表面蛋白1(MSP-1)和裂殖子表面蛋白2(MSP-2)被用于开发疫苗以及研究伊朗恶性疟原虫疟疾的基因多样性。采用巢式聚合酶链反应扩增来确定MSP-1第2区和MSP-2基因中央结构域的多态性。该试验纳入了来自伊朗东南部一个主要流行地区的67名经显微镜检查确诊为恶性疟原虫感染的个体。鉴定出了9个MSP-1等位基因和11个MSP-2等位基因。结果表明,这些表面抗原基因的扩增产物大小各异,且每个分离株都有特定的模式。此外,基于这种模式,观察到23例至少携带2个等位基因的多重感染。虽然伊朗的疟疾流行地区被归类为低至中度流行组,但每个标记都观察到了广泛的多态性,并且MSP-2中央重复序列是最多样化的,可用于设计疟疾疫苗。